Trials / Unknown
UnknownNCT05181150
Gut Peptides and Bone Remodeling in Individuals With Spinal Cord Injury
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- University of Copenhagen · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
Both GLP-2 and GIP reduce bone resorption (measured as CTX) in healthy persons. In this study, we will investigate whether GLP-2 and GIP is reducing CTX in individuals with spinal cord injury.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Meal test | Ingestion of an oral liquid meal (nutridrink), 200 mL. |
| OTHER | GIP | Subcutaneous GIP injection. |
| OTHER | GLP-2 | Subcutaneous GLP-2 injection. |
| OTHER | GIP + GLP-2 | Subcutaneous GIP + GLP-2 injection. |
| OTHER | Placebo | Subcutaneous saline injection. |
Timeline
- Start date
- 2021-11-16
- Primary completion
- 2024-11-01
- Completion
- 2024-11-01
- First posted
- 2022-01-06
- Last updated
- 2023-05-10
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT05181150. Inclusion in this directory is not an endorsement.